Source: Anais brasileiros de dermatologia. Unidade: FM
Subjects: CERATOSE, NEOPLASIAS FACIAIS, NEOPLASIAS CUTÂNEAS, NEOPLASIAS DE CABEÇA E PESCOÇO, GEL (FORMAS FARMACÊUTICAS)
ABNT
GAMEIRO, Luiz et al. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives. Anais brasileiros de dermatologia, v. 94, n. 3, p. 313-319, 2019Tradução . . Disponível em: https://doi.org/10.1590/abd1806-4841.20197938. Acesso em: 16 ago. 2024.APA
Gameiro, L., Tovo, L. F. R., Sanches Junior, J. A., & Aprahamian, I. (2019). Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives. Anais brasileiros de dermatologia, 94( 3), 313-319. doi:10.1590/abd1806-4841.20197938NLM
Gameiro L, Tovo LFR, Sanches Junior JA, Aprahamian I. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives [Internet]. Anais brasileiros de dermatologia. 2019 ; 94( 3): 313-319.[citado 2024 ago. 16 ] Available from: https://doi.org/10.1590/abd1806-4841.20197938Vancouver
Gameiro L, Tovo LFR, Sanches Junior JA, Aprahamian I. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives [Internet]. Anais brasileiros de dermatologia. 2019 ; 94( 3): 313-319.[citado 2024 ago. 16 ] Available from: https://doi.org/10.1590/abd1806-4841.20197938